In contrast, the first symptom in the CLN3 disease or classical juvenile NCL (age of onset 5–7 years) is a rapidly progressive loss of vision, followed by cognitive decline, behavior changes, and progressive epileptic seizures (1). The gene discussed is CLN3; the disease is neuronal ceroid lipofuscinosis.